Matthew Lowe is a Principal Clinical Scientist and Proton Treatment Planning Lead at The Christie NHS Foundation Trust.

Since completing a PhD in robustness to uncertainties in proton therapy in 2017, he has been involved in the commissioning, development and delivery of the clinical service at the proton therapy centre at The Christie.